Sanofi’s Beyfortus Receives ACIP Recommendation
Sanofi's Beyfortus Recommended for all Infants Following the news of FDA-approval of Beyfortus (nirsevimab-alip) in July, the ACIP has now recommended the use of Beyfortus for all infants. Beyfortus is indicated for the prevention of respiratory syncytial virus (RSV) lower respiratory tract disease in: · Neonates and infants...